| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 14.84 | -8.22 | 8.96 | -16.7 |
Op profit growth | 144.36 | -62.9 | 35.42 | -44.12 |
EBIT growth | 130.05 | -48.23 | -16.13 | -30.1 |
Net profit growth | -23.97 | 162.6 | 35.77 | 197.88 |
Profitability ratios (%) | ||||
OPM | 12.26 | 5.76 | 14.26 | 11.47 |
EBIT margin | 6.56 | 3.27 | 5.8 | 7.54 |
Net profit margin | -23.63 | -35.7 | -12.47 | -10.01 |
RoCE | 4.6 | 1.41 | 2.26 | 2.55 |
RoNW | 246.98 | -19.14 | -5.56 | -3.38 |
RoA | -4.14 | -3.84 | -1.21 | -0.84 |
Per share ratios (₹) | ||||
EPS | -24.11 | -31.72 | 0 | 0 |
Dividend per share | 0 | 0 | 0 | 0 |
Cash EPS | -31.55 | -38.77 | -21.63 | -19.98 |
Book value per share | -37.33 | 32.45 | 50.39 | 58.06 |
Valuation ratios | ||||
P/E | -7.35 | -3.16 | 0 | 0 |
P/CEPS | -5.62 | -2.59 | -11.32 | -7.37 |
P/B | -4.75 | 3.09 | 4.86 | 2.53 |
EV/EBIDTA | 20.44 | 21.67 | 27.46 | 18.01 |
Payout (%) | ||||
Dividend payout | 0 | 0 | 0 | 0 |
Tax payout | 1.35 | 10.65 | 14.9 | -18.34 |
Liquidity ratios | ||||
Debtor days | 44.74 | 68.6 | 85.64 | 95.21 |
Inventory days | 94 | 161.64 | 200.03 | 208.25 |
Creditor days | -148.93 | -169.45 | -188.79 | -165.4 |
Leverage ratios | ||||
Interest coverage | -0.22 | -0.1 | -0.34 | -0.4 |
Net debt / equity | -2.98 | 3.28 | 2.97 | 2.75 |
Net debt / op. profit | 8.92 | 20.8 | 10.85 | 15.69 |
Cost breakup (₹) | ||||
Material costs | -32.75 | -28.81 | -31.58 | -27.48 |
Employee costs | -24.99 | -26.15 | -25.57 | -27.22 |
Other costs | -29.98 | -39.25 | -28.57 | -33.81 |
Such a contract symbolizes Panacea Biotec's continued commitment toward global health by contributing its share of the fight against polio, a deadly disease prevalent in many pockets of the world.
Panacea Biotec's stock has seen a 37% gain over the past six months. Panacea Biotec's stock has gained a total of 76% in the last one year.
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
